---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-26-008782"
form_type: "8-K"
ticker: "SIGA"
cik: "0001010086"
company_name: "SIGA TECHNOLOGIES INC"
filed_at: "2026-03-10T23:59:59+00:00"
generated_at: "2026-05-15T15:24:59.714822+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# SIGA 2025 product revenue $88M, down 34% YoY; net income $23.3M vs $59.2M

## Summary
- Product revenues of $88M in 2025, down from $133M in 2024; total revenues $94.6M.
- Net income of $23.3M ($0.32 diluted EPS) vs $59.2M ($0.82) in 2024.
- Q4 product sales fell to $2.2M from $79.8M; operating loss of $9.5M.
- Received $13M international order for oral TPOXX in Jan 2026; delivery expected in 2026.
- BARDA 19C contract added $27M in development funding for pediatric program and manufacturing.

## SEC filing metadata
- accession: 0001140361-26-008782
- form_type: 8-K
- ticker: SIGA
- cik: 0001010086
- company_name: SIGA TECHNOLOGIES INC
- filed_at: 2026-03-10T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1010086/000114036126008782/0001140361-26-008782-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1010086/000114036126008782/ef20067458_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-26-008782
- JSON: https://secwatch.observer/filing/0001140361-26-008782.json
- Plain text: https://secwatch.observer/filing/0001140361-26-008782.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.